Can-Fite BioPharma CANF
NYSE CANF
$2.21 +0.03 (+1.61%)
As of: Sep 30, 2026 · 3:58 PM EDT

Can-Fite BioPharma (CANF) Current Taxes (2016 - 2017)

Updated

Can-Fite BioPharma's Current Taxes was $1.48 million in Q4 2017, down 69.2% from $4.8 million a year earlier.

Analysis

Can-Fite BioPharma (CANF) Current Taxes (2016 - 2017) Analysis & Trends

  • In earlier years, Current Taxes was $4.8 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.05 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 4.22 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 2.31 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -1.47 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 653.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 1.48 Mn
Dec 31, 2016 4.80 Mn
API Access

Can-Fite BioPharma Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=CANF&period=max&api_key=YOUR_API_KEY